D. E. Shaw & Co., Inc. Taro Pharmaceutical Industries LTD Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.77 - $42.31 $12,026 - $15,527	367 Added 3.68%	10,345 $432,000
Q3 2023 Nov 14, 2023	SELL	$35.46 - $40.13 $854,160 - $966,651	-24,088 Reduced 70.71%	9,978 $376,000
Q2 2023 Aug 14, 2023	SELL	$24.24 - $40.97 $475,782 - $804,159	-19,628 Reduced 36.56%	34,066 $1.29 Million
Q1 2023 May 15, 2023	SELL	$23.0 - $31.59 $45,034 - $61,853	-1,958 Reduced 3.52%	53,694 $1.31 Million
Q4 2022 Feb 14, 2023	BUY	$27.6 - $32.99 $11,122 - $13,294	403 Added 0.73%	55,652 $1.62 Million
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $74,235 - $103,061	-2,583 Reduced 4.47%	55,249 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$35.0 - $43.59 $45,955 - $57,233	-1,313 Reduced 2.22%	57,832 $2.09 Million
Q1 2022 May 16, 2022	BUY	$43.12 - $50.3 $135,569 - $158,143	3,144 Added 5.61%	59,145 $2.56 Million
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $152,082 - $207,675	-3,195 Reduced 5.4%	56,001 $2.81 Million
Q3 2021 Nov 15, 2021	SELL	$62.34 - $73.38 $196,246 - $231,000	-3,148 Reduced 5.05%	59,196 $3.77 Million
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $314,132 - $342,657	-4,471 Reduced 6.69%	62,344 $4.49 Million
Q1 2021 May 17, 2021	SELL	$70.48 - $79.95 $761,818 - $864,179	-10,809 Reduced 13.92%	66,815 $4.93 Million
Q4 2020 Feb 16, 2021	SELL	$54.4 - $73.42 $238,598 - $322,020	-4,386 Reduced 5.35%	77,624 $5.7 Million
Q3 2020 Nov 16, 2020	SELL	$54.41 - $68.2 $194,026 - $243,201	-3,566 Reduced 4.17%	82,010 $4.5 Million
Q2 2020 Aug 14, 2020	SELL	$61.66 - $70.16 $60,673 - $69,037	-984 Reduced 1.14%	85,576 $5.69 Million
Q1 2020 May 15, 2020	SELL	$59.35 - $88.73 $334,496 - $500,082	-5,636 Reduced 6.11%	86,560 $5.3 Million
Q4 2019 Feb 14, 2020	BUY	$74.18 - $97.92 $1.86 Million - $2.46 Million	25,118 Added 37.45%	92,196 $8.11 Million
Q3 2019 Nov 14, 2019	BUY	$75.36 - $86.57 $2.27 Million - $2.61 Million	30,132 Added 81.56%	67,078 $5.06 Million
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $807,646 - $1.05 Million	9,624 Added 35.22%	36,946 $3.16 Million
Q1 2019 May 15, 2019	SELL	$85.97 - $108.09 $1.25 Million - $1.57 Million	-14,523 Reduced 34.71%	27,322 $2.95 Million
Q4 2018 Feb 14, 2019	SELL	$78.25 - $107.92 $1.45 Million - $2 Million	-18,506 Reduced 30.66%	41,845 $3.54 Million
Q3 2018 Nov 14, 2018	BUY	$97.82 - $116.09 $1.88 Million - $2.23 Million	19,216 Added 46.71%	60,351 $5.93 Million
Q2 2018 Aug 14, 2018	BUY	$97.62 - $120.59 $541,107 - $668,430	5,543 Added 15.57%	41,135 $4.76 Million
Q1 2018 May 15, 2018	BUY	$95.91 - $107.26 $1.01 Million - $1.13 Million	10,494 Added 41.81%	35,592 $3.52 Million
Q4 2017 Feb 14, 2018	BUY	$104.5 - $126.38 $2.62 Million - $3.17 Million	25,098	25,098 $2.63 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account